USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/33076
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPortnoi, Elena-
dc.contributor.authorBrînza, Dumitru-
dc.contributor.authorFoca, Ecaterina-
dc.contributor.authorAdam, Consuela-
dc.contributor.authorPînzaru, Valeria-
dc.contributor.authorStratan, Valentina-
dc.contributor.authorFulga, Veaceslav-
dc.date.accessioned2026-04-07T06:54:58Z-
dc.date.available2026-04-07T06:54:58Z-
dc.date.issued2026-
dc.identifier.citationPORTNOI, Elena; Dumitru BRÎNZA; Ecaterina FOCA; Consuela ADAM; Valeria PÎNZARU; Valentina STRATAN and Veaceslav FULGA.Tumor-infiltrating CD79α positive lymphocytes in breast cancer. In: Cells and Tissues Transplantation. Actualities and Perspectives: The Materials of the National Scientific Conference with International Participation, the 4 th edition, Chisinau, March 20-21, 2026. Chișinău : CEP Medicina, 2026, p. 94. ISBN 978-9975-82-477-4 (PDF).en_US
dc.identifier.isbn978-9975-82-477-4-
dc.identifier.urihttps://repository.usmf.md/handle/20.500.12710/33076-
dc.description.abstractIntroduction. Tumor-infiltrating lymphocytes (TILs) represent a critical component of the immune microenvironment in breast cancer, influencing tumor progression and patient prognosis. Among Bcell markers, CD79α is a reliable indicator of mature B lymphocytes. However, its role in breast carcinoma, particularly in relation to histopathological parameters, remains insufficiently explored. This study aimed to evaluate the density and distribution of CD79α-positive lymphocytes in breast carcinoma and to assess their correlation with histological grade and the Nottingham score. Materials and Methods. A total of 19 cases of breast carcinoma were retrospectively selected from the archive of the Oncology Institute. Immunohistochemical staining for CD79α was performed, and positive lymphocytes were quantified separately in the intratumoral and peritumoral stromal compartments. Histological grade and the Nottingham score were recorded for each case. Descriptive statistical analysis was performed, and Pearson correlation coefficients were calculated to evaluate associations between CD79α expression and histopathological parameters. Statistical significance was defined as p ≤ 0.05. Results. The density of CD79α-positive lymphocytes varied across compartments, with higher values observed in the peritumoral stroma compared with intratumoral regions. Intratumoral CD79a expression showed a moderate positive correlation with peritumoral density (r = 0.41, p = 0.04). Peritumoral CD79α infiltration correlated significantly with histological grade (r = 0.52, p = 0.01), suggesting a link between B-cell presence in the tumor microenvironment and tumor aggressiveness. No significant associations were found between CD79α expression and patient age. The Nottingham score demonstrated a strong correlation with histological grade (r = 0.73, p < 0.001), confirming its robustness as a prognostic tool. Conclusions. Our findings indicate that CD79α-positive lymphocytes are more abundant in the peritumoral stroma of breast carcinoma and that their density correlates with histological grade. These results suggest that peritumoral B-cell infiltration may reflect tumor aggressiveness and could serve as a potential biomarker in breast cancer. Further studies with larger cohorts are warranted to validate the prognostic significance of CD79α -positive TILs and to explore their role in shaping the immune response within the tumor microenvironment.en_US
dc.language.isoenen_US
dc.publisherCEP Medicinaen_US
dc.relation.ispartofCells and Tissues Transplantation. Actualities and Perspectives: The Materials of the National Scientific Conference with International Participation, the 4 th edition, Chisinau, March 20-21, 2026en_US
dc.subjectbreast carcinomaen_US
dc.subjectCD79 αen_US
dc.subjecttumor-infiltrating lymphocytesen_US
dc.subjecthistological gradeen_US
dc.subjectNottingham scoreen_US
dc.titleTumor-infiltrating CD79α positive lymphocytes in breast canceren_US
dc.typeOtheren_US
Appears in Collections:Cells and Tissues Transplantation. Actualities and Perspectives: The Materials of the National Scientific Conference with International Participation, the 4 th edition, Chisinau, March 20-21, 2026

Files in This Item:
File Description SizeFormat 
TUMOR_INFILTRATING_CD79a_POSITIVE_LYMPHOCYTES_IN_BREAST_CANCER.pdf249.35 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback